Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina.

PURPOSE Recently, intravitreal injection of corticosteroids has been in wide use as a treatment for diabetic macular edema, and the outcomes have been favorable. However, the exact mechanism remains unclear. The hypothesis for the current study was that intravitreal corticosteroids may improve diabetic retinal edema by amelioration of blood-retinal barrier (BRB) breakdown, by inhibiting leukocyte stasis (leukostasis). METHODS Diabetes was induced in 6-week-old male Long-Evans rats by intraperitoneal injection of streptozotocin (75 mg/kg). Three weeks after induction of diabetes, intravitreal injection of dexamethasone (40 microg/10 microL) was performed. At 2 days after intravitreal injection, accumulated leukocytes were counted in vivo by acridine orange leukocyte fluorography, and BRB breakdown was evaluated by measurement of retinal vascular permeability. The mRNA expression and protein levels of intercellular adhesion molecule (ICAM)-1 in the retina were also studied. RESULTS The number of leukocytes accumulated in the retina, once increased in the diabetic group, was decreased by 31.6% (P = 0.0001) after dexamethasone injection. The level of BRB breakdown, also elevated in the diabetic group, was suppressed by 61.1% (P = 0.0046) after dexamethasone injection. The level of ICAM-1 mRNA expression and its protein, upregulated in the diabetic group, were downregulated by dexamethasone treatment by 70.0% (P < 0.0001) and 56.4% (P = 0.0003). CONCLUSIONS Intravitreal injection of corticosteroids improves diabetic retinal edema through inhibiting leukocyte recruitment in the diabetic retina.

[1]  K Miyamoto,et al.  In vivo demonstration of increased leukocyte entrapment in retinal microcirculation of diabetic rats. , 1998, Investigative ophthalmology & visual science.

[2]  Y. Ogura,et al.  Enhanced Expression of Adhesion Molecules of the Retinal Vascular Endothelium in Spontaneous Diabetic Rats , 2002, Ophthalmic Research.

[3]  J. Kiryu,et al.  In Vivo Evaluation of Retinal Injury After Transient Ischemia in Hypertensive Rats , 2004, Hypertension.

[4]  K. Yamashiro,et al.  VEGF164 is proinflammatory in the diabetic retina. , 2003, Investigative ophthalmology & visual science.

[5]  J. Jonas,et al.  Intravitreal injection of triamcinolone for diffuse diabetic macular edema. , 2003, Archives of ophthalmology.

[6]  Intravitreal Triamcinolone for Refractory Diabetic Macular Edema: Two-Year Results of a Double-Masked, Placebo-Controlled, Randomized Clinical TrialGillies MC, Sutter FKP, Simpson JM, et al (Univ of Sydney, Australia) Ophthalmology 113:1533–1538, 2006§ , 2007 .

[7]  Y. Ogura,et al.  Quantitative evaluation of leukocyte dynamics in retinal microcirculation. , 1995, Investigative ophthalmology & visual science.

[8]  Bernd Kirchhof,et al.  The FASEB Journal express article 10.1096/fj.02-0157fje. Published online November 15, 2002. Suppression of Fas-FasL-induced endothelial cell apoptosis , 2022 .

[9]  A. Tsujikawa,et al.  Simvastatin inhibits leukocyte accumulation and vascular permeability in the retinas of rats with streptozotocin-induced diabetes. , 2004, The American journal of pathology.

[10]  D. Lefer,et al.  Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. , 1995, The American journal of pathology.

[11]  S. Peters,et al.  Steroid Therapy of a Proliferating Hemangioma: Histochemical and Molecular Changes , 2000, Pediatrics.

[12]  Uday B Kompella,et al.  Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression. , 2003, Investigative ophthalmology & visual science.

[13]  J. Duker,et al.  Intravitreal triamcinolone for refractory diabetic macular edema. , 2002, Ophthalmology.

[14]  E. Wolpert,et al.  Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin , 2002, Journal of neurochemistry.

[15]  R. Bucala.  Neuroimmunomodulation by Macrophage Migration Inhibitory Factor (MIF) , 1998, Annals of the New York Academy of Sciences.

[16]  M. Komada,et al.  Vascular endothelial growth factor expression in choroidal neovascularization in rats , 1997, Graefe's Archive for Clinical and Experimental Ophthalmology.

[17]  V. Perry,et al.  Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood–brain barrier breakdown in vivo , 1998, Neuroscience.

[18]  K Miyamoto,et al.  Visualization and quantitative analysis of leukocyte dynamics in retinal microcirculation of rats. , 1996, Investigative ophthalmology & visual science.

[19]  M. Corada,et al.  Polymorphonuclear leukocyte adhesion triggers the disorganization of endothelial cell-to-cell adherens junctions , 1996, The Journal of cell biology.

[20]  W. Mieler,et al.  Intravitreal triamcinolone does not alter basal vascular endothelial growth factor mRNA expression in rat retina , 2004, Vision Research.

[21]  Bernd Kirchhof,et al.  Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. , 2002, The American journal of pathology.

[22]  Y. Ogura,et al.  Platelets accumulate in the diabetic retinal vasculature following endothelial death and suppress blood-retinal barrier breakdown. , 2003, The American journal of pathology.

[23]  B Kirchhof,et al.  Leukocyte-mediated endothelial cell injury and death in the diabetic retina. , 2001, The American journal of pathology.

[24]  W. Schaper,et al.  In vitro effects of dexamethasone on hypoxia-induced hyperpermeability and expression of vascular endothelial growth factor. , 2001, European journal of pharmacology.

[25]  H. Grossniklaus,et al.  Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. , 2002, Molecular vision.

[26]  D. Charnock-Jones,et al.  Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. , 1996, The Journal of clinical investigation.

[27]  A. Erginay,et al.  Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. , 2004 .

[28]  K. Miyarnoto.  Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition , 1999 .